Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Clinical trial NCT00730613 · COMPLETED
Trial details
- NCT number
- NCT00730613
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2011-08-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.